Clinical Trials in Tennessee

Showing 5741-5760 of 20,239 trials

Strategy to Avoid Excessive Oxygen in Major Burn Patients

NCT04534972

The objective is to determine the effectiveness of a multimodal educational intervention to reduce supplemental oxygen use in major burn patients. Investigators will also evaluate the safety and clinical effectiveness of the more targeted use of oxygen therapy.

Critical IllnessWounds and InjuryDisease Attributes+1 more

University of Colorado, Denver2,000 participantsStarted Apr 2021

Birmingham, Alabama, United States • Aurora, Colorado, United States • Cincinnati, Ohio, United States +3 more locations

Active Not RecruitingPhase 329 miles

Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome

NCT05701774

The purpose of this is study is to evaluate the long-term safety of DCCR (diazoxide choline) extended-release tablets) in patients with Prader-Willi syndrome.

Prader-Willi Syndrome

Soleno Therapeutics, Inc.83 participantsStarted Jan 2023

Orange, California, United States • Palo Alto, California, United States • San Diego, California, United States +19 more locations

Strategy to Avoid Excessive Oxygen in Major Burn Patients

Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome

Find Trials by Condition in Tennessee

To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF

Clinical Outcomes of the ALPS Proximal Humerus Plating System

Maximizing Outcomes for Preschoolers With Developmental Language Disorders

Clinical Safety and Efficacy of Infrared Neural Stimulation During Nerve Transfers

Testing the Effect of the Youth Mindful Awareness Program on Negative Affect

Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years

A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia

Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)

A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery

Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma

Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia

A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults

A Study of Real-life Current Standards of Care in Patients With Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including Proteasome Inhibitor (PI), Immunomodulatory Drug (IMID), and Cluster of Differentiation 38 (CD38) Monoclonal Antibody Treatment

Study Using CABENUVA™ for the Treatment of Human Immunodeficiency Virus (HIV)-1, Administered in Infusion Centers (IC) or Alternate Sites of Administration (ASA) in the United States (U.S.)

Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer

A Study of Guselkumab in Participants With Active Lupus Nephritis

XEN1101 for Major Depressive Disorder

EFS of Bioabsorbable Implant for NSD